Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis

Nature

Volumn 448, Issue 7153, 2007, Pages 609-612

  Ago, Hideo ^a   Kanaoka, Yoshihide ^b,c   Irikura, Daisuke ^a,b,c   Lam, Bing K ^b,c   Shimamura, Tatsuro ^a   Austen, K Frank ^b,c   Miyano, Masashi ^a  

^a Structural Biophysics Laboratory RIKEN SPring 8 Center Harima Institute ^*  (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXY 6 GLUTATHIONYL 7,9,11,14 EICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; ICOSANOID; MEMBRANE PROTEIN; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E SYNTHASE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ASTHMA; CRYSTAL STRUCTURE; ENZYME ACTIVITY; FATTY ACID; LIPID; MEMBRANE; METABOLISM; METABOLITE; PROTEIN; XENOBIOTICS;

ANAPHYLAXIS; ARTICLE; ASTHMA; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME SPECIFICITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; X RAY CRYSTALLOGRAPHY;

EID: 34547631962     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05936     Document Type: Article

References (31)

1. Kellaway, C. H. & Trethewie, W. R. The liberation of a slow reacting smooth muscle-stimulating substance in anaphylaxis. Q. J. Exp. Physiol. 30, 121-145 (1940).
2. Brocklehurst, W. E. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J. Physiol. (Lond.) 151, 416-435 (1960).
3. Dahlen, S. E., Hedqvist, P., Hammarstrom, S. & Samuelsson, B. Leukotrienes are potent constrictors of human bronchi. Nature 288, 484-486 (1980).
4. Dahlen, S. E. et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl Acad. Sci. USA 78, 3887-3891 (1981).
5. 4) in human skin. J. Invest. Dermatol. 80, 115-119 (1983).
6. Beller, T. C. et al. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc. Natl Acad. Sci. USA 101, 3047-3052 (2004).
7. Kim, D. C. et al. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. J. Immunol. 176, 4440-4448 (2006).
8. Weiss, J. W. et al. Bronchoconstrictor effects of leukotriene C in humans. Science 216, 196-198 (1982).
9. 4-receptor antagonist. N. Engl. J. Med. 323, 1736-1739 (1990).
10. Kanaoka, Y., Maekawa, A., Penrose, J. F., Austen, K. F. & Lam, B. K. Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase. J. Biol. Chem. 276, 22608-22613 (2001).
11. 4. Proc. Natl Acad. Sci. USA 91, 7663-7667 (1994).
12. 4 synthase. Proc. Natl Acad. Sci. USA 91, 9745-9749 (1994).
13. Bresell, A. et al. Bioinformatic and enzymatic characterization of the MAPEG superfamily. FEBS J. 272, 1688-1703 (2005).
14. Samuelsson, B., Dahlen, S. E., Lindgren, J. A., Rouzer, C. A. & Serhan, C. N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237, 1171-1176 (1987).
15. 4 synthase. J. Biol. Chem. 271, 22203-22210 (1996).
16. Jakobsson, P. J., Mancini, J. A., Riendeau, D. & Ford-Hutchinson, A. W. Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities. J. Biol. Chem. 272, 22934-22939 (1997).
17. 4 synthase of guinea pig lung. J. Clin. Invest. 81, 866-871 (1988).
18. 4 synthase at 4.5 Å resolution in projection. Structure 12, 2009-2014 (2004).
19. Holm, P. J. et al. Structural basis for detoxification and oxidative stress protection in membranes. J. Mol. Biol. 360, 934-945 (2006).
20. Thoren, S. et al. Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination. J. Biol. Chem. 278, 22199-22209 (2003).
21. 4 synthase. J. Biol. Chem. 277, 28902-28908 (2002).
22. Armstrong, R. N. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem. Res. Toxicol. 10, 2-18 (1997).
23. 4 synthase. J. Biol. Chem. 272, 13923-13928 (1997).
24. Guillen Schlippe, Y. V. & Hedstrom, L. A twisted base? The role of arginine in enzyme-catalyzed proton abstractions. Arch. Biochem. Biophys. 433, 266-278 (2005).
25. 4: competition with arachidonic acid but not other lipoxygenase products. J. Lipid Res. 45, 2138-2144 (2004).
26. Marfat, A. & Corey, E. J. Synthesis and structure elucidation of leukotrienes. Adv. Prostaglandin Thromboxane Leukot. Res. 14, 155-228 (1985).
27. Collaborative Computational Project Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760-763 (1994).
28. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
29. Brünger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921 (1998).
30. Adachi, S. et al. The RIKEN structural biology beamline II (BL44B2) at the SPring-8. Nucl. Instrum. Methods Phys. Res. A 467-468, 711-714 (2001).
31. Sheldrick, G. M. Macromolecular phasing with SHELXE. Z. Kristallogr. 217, 644-650 (2002).